Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Trilaciclib”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT06370416
What this trial is testing

The Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Who this might be right for
Non-small Cell Lung Cancer
Henan Cancer Hospital 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Early research (Phase 1)Looking for participantsNCT07490236
What this trial is testing

Trilaciclib in Combination With Chemotherapy in Patients With CDK4/6-Dependent Solid Tumors

Who this might be right for
TrilaciclibCDK4/6-dependent Solid Tumors
Hebei Medical University Fourth Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05862610
What this trial is testing

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

Who this might be right for
Breast Neoplasm
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07473128
What this trial is testing

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Pharmacosmos A/S 120
Testing effectiveness (Phase 2)UnknownNCT06328049
What this trial is testing

Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Who this might be right for
NSCLC
Taixing People's Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05978648
What this trial is testing

Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy

Who this might be right for
Breast Neoplasms
wang shusen 116
Post-approval studies (Phase 4)Study completedNCT05071703
What this trial is testing

Evaluation of TRILACICLIB in Chinese Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC) for Chemotherapy-induced Myelosuppression, Antitumor Effects of Combination Regimens, and Safety in a Real-world Study

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05910034
What this trial is testing

Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLC

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Fudan University 132
Testing effectiveness (Phase 2)Looking for participantsNCT06714383
What this trial is testing

Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma

Who this might be right for
Osteosarcoma
Peking University People's Hospital 50
Testing effectiveness (Phase 2)UnknownNCT06332287
What this trial is testing

Trilaciclib Combined With Chemotherapy in the Treatment of Advanced NSCLC With Leptomeningeal Metastasis

Who this might be right for
NSCLC
Jiangsu Province Nanjing Brain Hospital 25
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07160283
What this trial is testing

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Who this might be right for
Biliary Tract NeoplasmsPancreatic Neoplasms
The Second Affiliated Hospital of Shandong First Medical University 96
Testing effectiveness (Phase 2)Looking for participantsNCT06699472
What this trial is testing

A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib

Who this might be right for
Ewing SarcomaMyelosuppression
Fudan University 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06714266
What this trial is testing

Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06027268
What this trial is testing

Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Triple-Negative Breast Cancer
Wake Forest University Health Sciences 36
Testing effectiveness (Phase 2)Ended earlyNCT02978716
What this trial is testing

Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)

Who this might be right for
Triple-Negative Breast NeoplasmsBreast NeoplasmBreast Cancer+1 more
G1 Therapeutics, Inc. 102
Testing effectiveness (Phase 2)Looking for participantsNCT06698965
What this trial is testing

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

Who this might be right for
Lung Cancer, Small Cell
Shanghai Chest Hospital 52
Testing effectiveness (Phase 2)Study completedNCT03041311
What this trial is testing

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

Who this might be right for
Small Cell Lung Cancer
G1 Therapeutics, Inc. 107
Testing effectiveness (Phase 2)UnknownNCT05900921
What this trial is testing

Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

Who this might be right for
Advanced Squamous Non-Small-Cell Lung Cancer
Sichuan University 132
Load More Results